NO173998C - Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater

Info

Publication number
NO173998C
NO173998C NO883229A NO883229A NO173998C NO 173998 C NO173998 C NO 173998C NO 883229 A NO883229 A NO 883229A NO 883229 A NO883229 A NO 883229A NO 173998 C NO173998 C NO 173998C
Authority
NO
Norway
Prior art keywords
therapeutically active
benzimidazole derivatives
analogous procedures
preparing therapeutically
active benzimidazole
Prior art date
Application number
NO883229A
Other languages
English (en)
Norwegian (no)
Other versions
NO883229D0 (no
NO173998B (no
NO883229L (no
Inventor
Tomas Boerje Alminger
Rolf Axel Bergman
Hans Bundgaard
Per Lennart Lindberg
Gunnel Elisabeth Sunden
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8604998A external-priority patent/SE8604998D0/xx
Priority claimed from SE8605551A external-priority patent/SE8605551D0/xx
Priority claimed from SE8704049A external-priority patent/SE8704049D0/xx
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of NO883229D0 publication Critical patent/NO883229D0/no
Publication of NO883229L publication Critical patent/NO883229L/no
Publication of NO173998B publication Critical patent/NO173998B/no
Publication of NO173998C publication Critical patent/NO173998C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO883229A 1986-11-21 1988-07-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater NO173998C (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE8604998A SE8604998D0 (sv) 1986-11-21 1986-11-21 Novel pharmacological compounds
SE8605551A SE8605551D0 (sv) 1986-12-23 1986-12-23 Novel pharmacological compounds
SE8704049A SE8704049D0 (sv) 1987-10-16 1987-10-16 Novel pharmacological compounds
PCT/SE1987/000546 WO1988003921A1 (en) 1986-11-21 1987-11-20 New benzimidazole derivatives a process for production thereof and a pharmaceutical composition containing the same

Publications (4)

Publication Number Publication Date
NO883229D0 NO883229D0 (no) 1988-07-20
NO883229L NO883229L (no) 1988-09-16
NO173998B NO173998B (no) 1993-11-22
NO173998C true NO173998C (no) 1994-03-02

Family

ID=27355365

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883229A NO173998C (no) 1986-11-21 1988-07-20 Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater

Country Status (24)

Country Link
EP (3) EP0332647A1 (es)
JP (1) JPH02500744A (es)
KR (1) KR890700125A (es)
AT (1) ATE84032T1 (es)
AU (1) AU612129B2 (es)
DE (1) DE3783356T2 (es)
DK (1) DK365488A (es)
EG (1) EG18379A (es)
ES (1) ES2052603T3 (es)
FI (1) FI892454A0 (es)
GR (1) GR3007385T3 (es)
HU (1) HU204814B (es)
IE (2) IE940326L (es)
IL (1) IL84504A (es)
IS (1) IS1565B (es)
LV (1) LV10954B (es)
MY (1) MY101784A (es)
NO (1) NO173998C (es)
NZ (2) NZ222495A (es)
PL (1) PL157655B1 (es)
PT (1) PT86186B (es)
RU (1) RU2062778C1 (es)
WO (1) WO1988003921A1 (es)
YU (1) YU47116B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8801907D0 (sv) * 1988-05-20 1988-05-20 Haessle Ab Novel pharmacological compounds
AU617217B2 (en) * 1988-09-20 1991-11-21 Hisamitsu Pharmaceutical Co., Inc. Novel dibenz(b,e)oxepin derivatives
IE64199B1 (en) * 1988-12-22 1995-07-12 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
SE8804629D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5274099A (en) * 1989-12-20 1993-12-28 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US5049674A (en) * 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
SE9002206D0 (sv) 1990-06-20 1990-06-20 Haessle Ab New compounds
CA2083606C (en) * 1990-06-20 2001-08-21 Arne Elof Brandstrom Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
ATE191213T1 (de) * 1990-10-17 2000-04-15 Takeda Chemical Industries Ltd Pyridin-derivate, verfahren zu deren herstellung und anwendung
SE9103776D0 (sv) * 1991-12-19 1991-12-19 Astra Ab New compounds
KR0185225B1 (ko) * 1992-05-21 1999-05-15 오오쓰까 아끼히꼬 포스폰산 디에스테르 유도체
WO1994026279A1 (en) * 1993-05-18 1994-11-24 The Upjohn Company Bisphosphonate esters for treating gastric disorders
US6875872B1 (en) 1993-05-28 2005-04-05 Astrazeneca Compounds
EP0983263A1 (en) * 1997-05-30 2000-03-08 Dr. Reddy's Research Foundation Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
US5985856A (en) * 1997-12-31 1999-11-16 University Of Kansas Water soluble prodrugs of secondary and tertiary amine containing drugs and methods of making thereof
US20020103161A1 (en) 1999-12-17 2002-08-01 Manfred Weigele Novel heterocycles
US20040039027A1 (en) * 2000-10-12 2004-02-26 Keiji Kamiyama Benzimidazole compounds, process for producing the same and use thereof
EP1437352A4 (en) * 2001-09-25 2004-12-08 Takeda Chemical Industries Ltd BENZYMIDAZOLE COMPOUND, PROCESS FOR PRODUCING AND USING THE SAME
PL1913009T3 (pl) * 2005-07-28 2010-10-29 Intervet Int Bv Nowe (tio)karbaminiany benzimidazolu o działaniu przeciwpasożytniczym i sposób ich wytwarzania
WO2016061190A1 (en) 2014-10-14 2016-04-21 The Board Of Trustees Of The Leland Stanford Junior University Method for treating neurodegenerative diseases
AU2016371598B2 (en) 2015-12-15 2021-05-13 The Board Of Trustees Of The Leland Stanford Junior University Method for preventing and/or treating aging-associated cognitive impairment and neuroinflammation
IL298535B2 (en) 2018-08-06 2024-03-01 Univ Leland Stanford Junior 2-Arylbenzimidazoles as PPARGC1A stimulators for the treatment of neurodegenerative diseases
CA3150303A1 (en) * 2019-08-20 2021-02-25 Ono Pharmaceutical Co., Ltd. Salt and crystal form of compound having agonistic activity to s1p5 receptor

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (sv) 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
SE416649B (sv) 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (es) 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS5836312B2 (ja) * 1978-08-21 1983-08-08 日本電信電話株式会社 通信用平衡ケ−ブル線路の障害位置測定方式
JPS5687818A (en) * 1979-12-19 1981-07-16 Ishikawajima Harima Heavy Ind Co Ltd Reflex type position detector
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
JPS57137860A (en) * 1981-02-20 1982-08-25 Sumitomo Electric Ind Ltd Optical tachometer
JPS5999597A (ja) * 1982-11-30 1984-06-08 株式会社東芝 光学測定装置
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
JPS6020051U (ja) * 1983-07-19 1985-02-12 三洋電機株式会社 カセツト収納装置
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds

Also Published As

Publication number Publication date
NZ234564A (en) 1991-04-26
IE873125L (en) 1988-05-21
NO883229D0 (no) 1988-07-20
NO173998B (no) 1993-11-22
DK365488D0 (da) 1988-07-01
DE3783356D1 (de) 1993-02-11
LV10954B (en) 1996-08-20
HU204814B (en) 1992-02-28
ES2052603T3 (es) 1994-07-16
FI892454A (fi) 1989-05-19
PT86186B (pt) 1990-08-31
YU47116B (sh) 1994-12-28
KR890700125A (ko) 1989-03-02
IE61178B1 (en) 1994-10-05
JPH02500744A (ja) 1990-03-15
IS3284A7 (is) 1988-05-22
PT86186A (en) 1987-12-01
DE3783356T2 (de) 1993-04-15
GR3007385T3 (es) 1993-07-30
EP0510719A1 (en) 1992-10-28
EP0279149B1 (en) 1992-12-30
EP0279149A2 (en) 1988-08-24
FI892454A0 (fi) 1989-05-19
IE940326L (en) 1988-05-21
NZ222495A (en) 1991-04-26
IS1565B (is) 1994-12-13
MY101784A (en) 1992-01-17
IL84504A (en) 1994-10-07
RU2062778C1 (ru) 1996-06-27
AU612129B2 (en) 1991-07-04
WO1988003921A1 (en) 1988-06-02
EG18379A (en) 1992-11-30
PL157655B1 (pl) 1992-06-30
ATE84032T1 (de) 1993-01-15
DK365488A (da) 1988-07-01
NO883229L (no) 1988-09-16
AU8330287A (en) 1988-06-16
LV10954A (lv) 1995-12-20
EP0332647A1 (en) 1989-09-20
HUT51269A (en) 1990-04-28
EP0279149A3 (en) 1988-08-31
PL268927A1 (en) 1989-01-23
YU211087A (en) 1988-12-31

Similar Documents

Publication Publication Date Title
NO173998C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
MY101791A (en) New benzimidazole derivatives
SE8300736D0 (sv) Novel pharmacologically active compounds
SE8804629D0 (sv) New therapeutically active compounds
SE8404065D0 (sv) Novel biologically active compounds
SE8600658D0 (sv) Novel composition of matter
NO174963C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 8-fluorantracyklinglucosider
SE8704049D0 (sv) Novel pharmacological compounds
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)
JO1653B1 (en) The current benzimidazole is a therapeutically active method for preparing it